Randy Dockens

Randy Dockens possesses extensive experience in clinical operations and pharmacology, currently serving as a Clinical Operations Lead at Bristol-Myers Squibb since May 1991, where responsibilities include spearheading the operational execution of clinical studies through various phases of development to regulatory approval. Previous roles at Bristol-Myers Squibb encompass Group Director of Clinical Pharmacology Scientific Operations and Director, where leadership involved overseeing teams of scientists and pharmacologists while ensuring high-quality study execution and innovative trial design. Earlier experience includes positions as Principal Research Scientist, Senior Research Investigator, and Pharmacokinetic Reviewer at the FDA, with a focus on pharmacokinetics in Phase 1 studies. Educational credentials include a Ph.D. in Pharmacokinetics and a Bachelor's Degree in Pharmacy from Auburn University.